New Tamper Resistant Oxycodone Product Approved

FDA has approved OXECTATM Tablets CII, an oxycodone HC1 product that is designed to discourage common methods of tampering associated with opioid abuse and misuse. OXECTA is an immediate-release oxycodone HCl medicine for the management of acute and chronic moderate to severe pain that applies technology designed to discourage tampering. More information is available on the Pharmaceutical & Medical Packaging News Web site.